Tradestie Institutional Equity Comparison Engine
JBSS vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
JBSS Overall Edge
JBSS Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to John B. Sanfilippo & SON (JBSS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, JBSS trades at 10.1x Forward P/E with 6.7% operating margin (-3.5% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, JBSS sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
JBSS
JBSS 10.1x vs BHST N/M Fwd P/E
Growth & Margin Winner
JBSS
Op Margin 6.7% vs -18.0% ยท YoY -3.5% vs +3.8%
Momentum & Technical Winner
JBSS
1Y -11.4% vs -79.4% ยท 52W Pos 25% vs 6%
Options & Structure Winner
JBSS
BREAKDOWN (18th %ile IV) vs UNCLASSIFIED (N/A IV)
JBSS
NASDAQ
John B. Sanfilippo & SON
Sugar & Confectionery Products
$61.07
+0.49% 1D
Market Cap
$710.6M
1M Return
-10.55%
1Y Return
-11.36%
Forward P/E
10.1x
Unified AI Score
47.3 / 100
HOLD
Tech 53.0
Fund 55.0
Flow 62.0
Mom 50.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
JBSS -11.36%
BHST -79.4%
Spread: +68.04 pp (JBSS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | JBSS Revenue | BHST Revenue | JBSS Op. Margin | BHST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $880M | N/A | 6.7% | N/A | JBSS |
| FY2020 | $880M | N/A | 8.9% | N/A | JBSS |
| FY2021 | $860M | N/A | 9.9% | N/A | JBSS |
| FY2022 | $960M | N/A | 9.1% | N/A | JBSS |
| FY2023 | $1.00B | $10M | 9.0% | -78.6% | JBSS |
| FY2024 | $1.07B | $30M | 8.0% | -27.7% | JBSS |
| FY2025 | $1.11B | $30M | 7.7% | -16.2% | JBSS |
| FY2026 | $1.18B | N/A | 7.6% | N/A | JBSS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | JBSS | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $710.6M | $29.9M | Larger Scale | JBSS |
| Trailing P/E Ratio Valuation | 12.7x | N/M | Lower Multiple | JBSS |
| Forward P/E Ratio Valuation | 10.1x | N/M | Lower Multiple | JBSS |
| Revenue Growth (YoY) Growth | -3.5% | +3.8% | Higher Growth | BHST |
| Operating Margin (TTM) Profitability | 6.7% | -18.0% | Higher Margin | JBSS |
| Net Profit Margin Profitability | 4.8% | -31.2% | Higher Margin | JBSS |
| Return on Equity (ROE) Capital Efficiency | 15.4% | -142.5% | Higher ROE | JBSS |
| 52-Week Range Position Momentum | 25% ($51โ$92) | 6% ($1โ$7) | Stronger Trend | JBSS |
| Beta / 30D Volatility Risk Regime | 0.21ฮฒ ยท 62% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | JBSS |
| Unified Institutional Score Composite Signal | 47.3 / 100 (HOLD) | 58.2 / 100 (HOLD) | Higher Composite | BHST |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full JBSS vs BHST Buy Guide
JBSS
BREAKDOWN
99d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
18th %ile
IV Regime
Compressed (<25th %ile)
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither JBSS nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.